Literature DB >> 26138140

Cytotoxic Edema in Posterior Reversible Encephalopathy Syndrome: Correlation of MRI Features with Serum Albumin Levels.

B Gao1, B X Yu2, R S Li2, G Zhang2, H Z Xie2, F L Liu2, C Lv3.   

Abstract

BACKGROUND AND
PURPOSE: Posterior reversible encephalopathy syndrome is a clinicoradiologic entity with typical MR imaging showing predominant vasogenic and occasional cytotoxic edema. It is unclear whether MR imaging correlates with levels of serum albumin. We determined potential risk factors for development of cytotoxic edema in posterior reversible encephalopathy syndrome.
MATERIALS AND METHODS: Seventy-nine cases with typical clinical symptoms and characteristic neuroradiologic findings conformed to posterior reversible encephalopathy syndrome diagnostic criteria and were included in this study. FLAIR, DWI, and ADC maps were interpreted to evaluate the severity and type of edema. MR imaging was correlated with the levels of serum albumin, and cytotoxic edema was compared with the location and severity of brain edema.
RESULTS: Pure vasogenic edema was found in 53 cases (67.09%), and vasogenic edema complicated with cytotoxic components, in 26 patients (32.91%). There was no difference in serum albumin levels between patients with cytotoxic components and those with vasogenic edema (P = .983). There was a significant difference in the edema scale scores between patients with cytotoxic edema and those with vasogenic edema (P = .006). The percentage of cytotoxic edema located in the area with higher scale scores of edema was significantly larger than that in areas with lower scale scores of edema (P = .002).
CONCLUSIONS: Serum albumin may contribute to the development of edema in PRES but is not a decisive factor for edema type. Cytotoxic edema in posterior reversible encephalopathy syndrome is probably related to regional decreased perfusion and arteriolopathy. Further work should be undertaken to discover the pathophysiologic mechanisms involved.
© 2015 by American Journal of Neuroradiology.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26138140      PMCID: PMC7965038          DOI: 10.3174/ajnr.A4379

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  35 in total

1.  Colloid osmotic pressure and the formation of posttraumatic cerebral edema.

Authors:  John C Drummond
Journal:  Anesthesiology       Date:  2010-05       Impact factor: 7.892

2.  Posterior reversible encephalopathy syndrome: the endothelial hypotheses.

Authors:  A Marra; M Vargas; P Striano; L Del Guercio; P Buonanno; G Servillo
Journal:  Med Hypotheses       Date:  2014-03-01       Impact factor: 1.538

3.  Posterior Reversible Encephalopathy Syndrome: The Spectrum of MR Imaging Patterns.

Authors:  O Kastrup; M Schlamann; C Moenninghoff; M Forsting; S Goericke
Journal:  Clin Neuroradiol       Date:  2014-02-20       Impact factor: 3.649

4.  Catheter angiography, MR angiography, and MR perfusion in posterior reversible encephalopathy syndrome.

Authors:  W S Bartynski; J F Boardman
Journal:  AJNR Am J Neuroradiol       Date:  2007-12-13       Impact factor: 3.825

5.  Posterior leukoencephalopathy following intrathecal chemotherapy with MRA-documented vasospasm.

Authors:  R D Henderson; T Rajah; A J Nicol; S J Read
Journal:  Neurology       Date:  2003-01-28       Impact factor: 9.910

6.  Posterior reversible encephalopathy syndrome: incidence of atypical regions of involvement and imaging findings.

Authors:  Alexander M McKinney; James Short; Charles L Truwit; Zeke J McKinney; Osman S Kozak; Karen S SantaCruz; Mehmet Teksam
Journal:  AJR Am J Roentgenol       Date:  2007-10       Impact factor: 3.959

7.  Blood-retina-barrier disruption accompanying blood-brain-barrier dysfunction in posterior reversible encephalopathy syndrome.

Authors:  Esra Ozkan; Rahsan Gocmen; Mehmet Akif Topcuoglu; Ethem Murat Arsava
Journal:  J Neurol Sci       Date:  2014-08-29       Impact factor: 3.181

8.  Acute toxic leukoencephalopathy: potential for reversibility clinically and on MRI with diffusion-weighted and FLAIR imaging.

Authors:  Alexander M McKinney; Stephen A Kieffer; Rogerich T Paylor; Karen S SantaCruz; Ayse Kendi; Leandro Lucato
Journal:  AJR Am J Roentgenol       Date:  2009-07       Impact factor: 3.959

9.  Is posterior reversible encephalopathy syndrome really reversible? Autopsy findings 4.5 years after radiographic resolution.

Authors:  Cyril Jacquot; Christine M Glastonbury; Tarik Tihan
Journal:  Clin Neuropathol       Date:  2015 Jan-Feb       Impact factor: 1.368

10.  Posterior reversible encephalopathy syndrome: prognostic utility of quantitative diffusion-weighted MR images.

Authors:  Diego J Covarrubias; Patrick H Luetmer; Norbert G Campeau
Journal:  AJNR Am J Neuroradiol       Date:  2002 Jun-Jul       Impact factor: 3.825

View more
  14 in total

1.  Posterior reversible encephalopathy syndrome coexists with acute cerebral infarction: challenges of blood pressure management.

Authors:  Luji Liu; Lihong Zhang
Journal:  Quant Imaging Med Surg       Date:  2020-12

2.  Reply.

Authors:  S Khanipour Roshan; A M McKinney; S J Karia; H Tore; J B Rykken
Journal:  AJNR Am J Neuroradiol       Date:  2016-06-30       Impact factor: 3.825

Review 3.  Stroke-like migraine attacks after radiation therapy syndrome: Case report and review of the literature.

Authors:  Achint K Singh; Bundhit Tantiwongkosi; Anna-Marieta Moise; Wilson B Altmeyer
Journal:  Neuroradiol J       Date:  2017-06-23

4.  Uremic encephalopathy: A definite diagnosis by magnetic resonance imaging?

Authors:  Farzad Sina; Darya Najafi; Alireza Aziz-Ahari; Elham Shahraki; Tahere Zarouk Ahimahalle; Zeinab Namjoo; Sajad Hassanzadeh
Journal:  Eur J Transl Myol       Date:  2022-08-12

5.  Uremic Encephalopathy: MR Imaging Findings and Clinical Correlation.

Authors:  D M Kim; I H Lee; C J Song
Journal:  AJNR Am J Neuroradiol       Date:  2016-04-28       Impact factor: 3.825

6.  Risk factors for poor outcome in posterior reversible encephalopathy syndrome: systematic review and meta-analysis.

Authors:  Zheng Chen; Gang Zhang; Alexander Lerner; An-Hui Wang; Bo Gao; Jie Liu
Journal:  Quant Imaging Med Surg       Date:  2018-05

7.  A randomized double-blind placebo-controlled trial of intravenous thiamine for prevention of delirium following allogeneic hematopoietic stem cell transplantation.

Authors:  Zev M Nakamura; Allison M Deal; Eliza M Park; Laura J Quillen; Stephanie A Chien; Kate E Stanton; Sean D McCabe; Hillary M Heiling; William A Wood; Thomas C Shea; Donald L Rosenstein
Journal:  J Psychosom Res       Date:  2021-04-27       Impact factor: 4.620

Review 8.  Posterior reversible encephalopathy syndrome.

Authors:  Marlene Fischer; Erich Schmutzhard
Journal:  J Neurol       Date:  2017-01-04       Impact factor: 4.849

Review 9.  Reversible posterior leukoencephalopathy syndrome due to adrenal pheochromocytoma: A case report and literature review.

Authors:  Bo Han; Yi Li; Maozhi Tang; Shun Wu; Xiaosong Xu
Journal:  Medicine (Baltimore)       Date:  2020-07-10       Impact factor: 1.817

10.  Cerebellar Parieto-occipital Posterior Reversible Encephalopathy Syndrome and Cerebral Metamorphopsia Associated with Asymptomatic Atrial Septum Vegetation and Renal Disease: Case Report.

Authors:  Arash Ghaffari-Rafi; Anthony C Netzel; Madeline Prat; Daniel T Miles
Journal:  Am J Case Rep       Date:  2020-06-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.